These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2267390)

  • 1. [Radiotherapy of rhinopharyngeal carcinoma: analysis of the caseload of Varese (1979-1986)].
    Antognoni P; Bossi A; Molteni M; Richetti A; Tordiglione M
    Radiol Med; 1990 Nov; 80(5):703-8. PubMed ID: 2267390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exclusive radiotherapy of carcinoma of the hypopharynx. Retrospective study of a series of 100 patients].
    Antognoni P; Bossi A; Cerizza L; Esposito E; Molteni M; Richetti A; Vavassori V; Tordiglione M
    Radiol Med; 1991 Sep; 82(3):328-33. PubMed ID: 1947270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exclusive radiotherapy of locally advanced carcinoma of the larynx. Analysis of the caseload of Varese (1979-1986)].
    Antognoni P; Bossi A; Molteni M; Richetti A; Tordiglione M
    Radiol Med; 1990 Dec; 80(6):898-902. PubMed ID: 2281175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
    Jereczek-Fossa BA; Morra A; DeBraud F; Alterio D; Mazzetta C; Rocca A; Catalano G; Bianchi L; Pasetti M; Chiesa F; Bruschini R; Orecchia R
    Strahlenther Onkol; 2004 Jul; 180(7):425-33. PubMed ID: 15241530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
    Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy].
    Hu Y; Lu T; Mai W; Han F; Huang Y; Liu H; Zhang E
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):463-7. PubMed ID: 12761966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
    Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
    Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of poorly-differentiated squamous cell carcinoma of the nasopharynx.
    Mitsuhashi N; Niibe H; Hayakawa K; Tamaki Y; Takahashi M; Yamakawa M; Hashida I; Akimoto T; Kiryu Y
    Jpn J Clin Oncol; 1994 Aug; 24(4):191-8. PubMed ID: 8072197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer].
    Xie CY; Wu SX; Jin XC; Yu JY; Wang JH; Li WF; Zhang P
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2412-5. PubMed ID: 18036320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for loco-regional control and outcome of re-irradiation for patients with poorly-differentiated squamous cell carcinoma of the nasopharynx.
    Mitsuhashi N; Sakurai H; Takahashi M; Maebayashi K; Tamaki Y; Hashida I; Akimoto T; Nakamoto S; Takahashi T; Hayakawa K
    Jpn J Clin Oncol; 1995 Jun; 25(3):72-8. PubMed ID: 7596051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
    Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
    Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.